[b]Effects of Continuing or Stopping Alendronate After 5 Years of Treatment[/b] Women who discontinued alendronate after 5 years showed a moderate decline in BMD and a gradual rise in biochemical markers but no higher fracture risk other than for clinical vertebral fractures compared with those who continued alendronate. These results suggest that for many women, discontinuation of alendronate for up to 5 years does not appear to significantly increase fracture risk. However, women at very high risk of clinical vertebral fractures may benefit by continuing beyond 5 years. Full Article on JAMA @ http://jama.ama-assn.org/cgi/content/abstract/296/24/2927